Market Overview:
The Europe generic drug market is currently witnessing strong growth. Generic drugs are pharmaceutical drugs with an equivalent therapeutic effect as their branded counterparts. These drugs are also identical to the innovator drug in terms of safety, strength, quality, dosage route of administration and intended usage. Unlike branded drugs, generic drugs are cost-efficient and do not require hefty investments on marketing campaigns or clinical studies.
Governments of various countries in Europe are undertaking initiatives to maintain a stable supply of medicines and support the Supplementary Protection Certificate (SPC) manufacturing waiver. This represents one of the significant factors propelling the growth of the generic drug market in Europe. Other factors driving the market are low production costs of generic drugs compared to their counterparts. This is attracting manufacturers to make capital investments in the industry. However, due to the surge in the coronavirus disease (COVID-19) cases, governing agencies have implemented lockdown restrictions in several countries. This has disrupted the manufacturing of generic drugs in Europe, but the market will experience growth once the cases start subsiding and lockdown restrictions are uplifted. Looking forward, the market is expected to continue its strong growth during the forecast period (2021-2026).
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the Europe generic drug market report, along with forecasts for growth at the region level from 2021-2026. Our report has categorized the market based on region, segment, therapy area, drug delivery and distribution channel.
Breakup by Segment:
- Unbranded Generics
- Branded Generics
Breakup by Therapy Area:
- Central Nervous System
- Cardiovascular
- Dermatology
- Genitourinary/Hormonal
- Respiratory
- Rheumatology
- Diabetes
- Oncology
- Others
Breakup by Drug Delivery:
- Oral
- Injectables
- Dermal/Topical
- Inhalers
Breakup by Distribution Channel:
Breakup by Country:
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Key Questions Answered in This Report:
- How has the Europe generic drug market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Europe generic drug market?
- What are the key regional markets?
- What is the breakup of the market based on the segment?
- What is the breakup of the market based on the therapy area?
- What is the breakup of the market based on the drug delivery?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the Europe generic drug market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Europe Generic Drug Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Segment
6.1 Unbranded Generics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Branded Generics
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Therapy Area
7.1 Central Nervous System
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Cardiovascular
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Dermatology
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Genitourinary/Hormonal
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Respiratory
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Rheumatology
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Diabetes
7.7.1 Market Trends
7.7.2 Market Forecast
7.8 Oncology
7.8.1 Market Trends
7.8.2 Market Forecast
7.9 Others
7.9.1 Market Trends
7.9.2 Market Forecast
8 Market Breakup by Drug Delivery
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injectables
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Dermal/Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Inhalers
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Distribution Channel
9.1 Retail Pharmacies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospital Pharmacies
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Country
10.1 Germany
10.1.1 Market Trends
10.1.2 Market Breakup by Segment
10.1.3 Market Breakup by Therapy Area
10.1.4 Market Breakup by Drug Delivery
10.1.5 Market Breakup by Distribution Channel
10.1.6 Market Forecast
10.2 France
10.2.1 Market Trends
10.2.2 Market Breakup by Segment
10.2.3 Market Breakup by Therapy Area
10.2.4 Market Breakup by Drug Delivery
10.2.5 Market Breakup by Distribution Channel
10.2.6 Market Forecast
10.3 United Kingdom
10.3.1 Market Trends
10.3.2 Market Breakup by Segment
10.3.3 Market Breakup by Therapy Area
10.3.4 Market Breakup by Drug Delivery
10.3.5 Market Breakup by Distribution Channel
10.3.6 Market Forecast
10.4 Italy
10.4.1 Market Trends
10.4.2 Market Breakup by Segment
10.4.3 Market Breakup by Therapy Area
10.4.4 Market Breakup by Drug Delivery
10.4.5 Market Breakup by Distribution Channel
10.4.6 Market Forecast
10.5 Spain
10.5.1 Market Trends
10.5.2 Market Breakup by Segment
10.5.3 Market Breakup by Therapy Area
10.5.4 Market Breakup by Drug Delivery
10.5.5 Market Breakup by Distribution Channel
10.5.6 Market Forecast
10.6 Others
10.6.1 Market Trends
10.6.2 Market Breakup by Segment
10.6.3 Market Breakup by Therapy Area
10.6.4 Market Breakup by Drug Delivery
10.6.5 Market Breakup by Distribution Channel
10.6.6 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Policy and Regulatory Landscape
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
List of Figures
Figure 1: Europe: Generic Drug Market: Major Drivers and Challenges
Figure 2: Europe: Generic Drug Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 5: Europe: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 6: Europe: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 7: Europe: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 8: Europe: Generic Drug Market: Breakup by Country (in %), 2020
Figure 9: Europe: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Europe: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Europe: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Europe: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Europe: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Europe: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Europe: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Europe: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Europe: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Europe: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Europe: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Europe: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Europe: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Europe: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Europe: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Europe: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Europe: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Europe: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Europe: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Europe: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: Europe: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: Europe: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: Europe: Generic Drug (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: Europe: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Europe: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Europe: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Europe: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Europe: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: Europe: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: Europe: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Europe: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Europe: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: Europe: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: Europe: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: Germany: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: Germany: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 45: Germany: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 46: Germany: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 47: Germany: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 48: Germany: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: France: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: France: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 51: France: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 52: France: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 53: France: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 54: France: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: United Kingdom: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: United Kingdom: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 57: United Kingdom: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 58: United Kingdom: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 59: United Kingdom: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 60: United Kingdom: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Italy: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Italy: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 63: Italy: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 64: Italy: Generic Drug Market: Breakup by Drug Delivery (in %), 2020
Figure 65: Italy: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 66: Italy: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Spain: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Spain: Generic Drug Market: Breakup by Segment (in %), 2020
Figure 69: Spain: Generic Drug Market: Breakup by Therapy Area (in %), 2020
Figure 70: Spain: Generic Drug Market: Breakup by Drug Channel (in %), 2020
Figure 71: Spain: Generic Drug Market: Breakup by Distribution Channel (in %), 2020
Figure 72: Spain: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Europe Generic Drug Industry: SWOT Analysis
Figure 76: Europe: Generic Drug Industry: Value Chain Analysis
Figure 77: Europe: Generic Drug Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Europe: Generic Drug Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2021-2026
Table 3: Europe: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2021-2026
Table 4: Europe: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2021-2026
Table 5: Europe: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2021-2026
Table 6: Europe: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 7: Europe: Generic Drug Market: Competitive Structure
Table 8: Europe: Generic Drug Market: Key Players